Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.416 EUR
−30.94 M EUR
0.00 EUR
58.20 M
About FARON PHARMACEUTICALS OY ORD NPV (DI)
Sector
CEO
Juho Markku Jalkanen
Headquarters
Turku
Website
Founded
2003
ISIN
FI4000153309
FIGI
BBG00R0D9FX2
Faron Pharmaceuticals Oy is a clinical stage biopharmaceutical company, which engages in the development of drugs to treat acute respiratory distress syndrome. Its main drug candidates include Traumakine and Bex. The company was founded by Juho Markku Jalkanen, Sirpa Tuulikki Jalkanen, Matti Esa Manner, Juha Veikko Peltola, Marko Salmi, Katriina Peltola and Maija-Leena Hollmen, and Markku Tapani Jalkanen in 2003 and is headquartered in Turku, Finland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of FARON is 1.910 EUR — it has decreased by −0.52% in the past 24 hours. Watch FARON PHARMACEUTICALS OY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXHEX exchange FARON PHARMACEUTICALS OY stocks are traded under the ticker FARON.
FARON stock has fallen by −3.05% compared to the previous week, the month change is a −28.60% fall, over the last year FARON PHARMACEUTICALS OY has showed a −26.55% decrease.
We've gathered analysts' opinions on FARON PHARMACEUTICALS OY future price: according to them, FARON price has a max estimate of 2.80 EUR and a min estimate of 1.20 EUR. Watch FARON chart and read a more detailed FARON PHARMACEUTICALS OY stock forecast: see what analysts think of FARON PHARMACEUTICALS OY and suggest that you do with its stocks.
FARON reached its all-time high on Mar 20, 2020 with the price of 10.384 EUR, and its all-time low was 1.054 EUR and was reached on Jun 19, 2024. View more price dynamics on FARON chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
FARON stock is 3.67% volatile and has beta coefficient of 2.01. Track FARON PHARMACEUTICALS OY stock price on the chart and check out the list of the most volatile stocks — is FARON PHARMACEUTICALS OY there?
Yes, you can track FARON PHARMACEUTICALS OY financials in yearly and quarterly reports right on TradingView.
FARON PHARMACEUTICALS OY is going to release the next earnings report on Mar 21, 2025. Keep track of upcoming events with our Earnings Calendar.
FARON earnings for the last half-year are −0.17 EUR per share, whereas the estimation was −0.16 EUR, resulting in a −3.09% surprise. The estimated earnings for the next half-year are −0.15 EUR per share. See more details about FARON PHARMACEUTICALS OY earnings.
FARON PHARMACEUTICALS OY revenue for the last half-year amounts to 0.00 EUR, despite the estimated figure of 0.00 EUR. In the next half-year revenue is expected to reach 50.00 EUR.
FARON net income for the last half-year is −14.39 M EUR, while the previous report showed −17.21 M EUR of net income which accounts for 16.38% change. Track more FARON PHARMACEUTICALS OY financial stats to get the full picture.
No, FARON doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 34.00 employees. See our rating of the largest employees — is FARON PHARMACEUTICALS OY on this list?
Like other stocks, FARON shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FARON PHARMACEUTICALS OY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FARON PHARMACEUTICALS OY technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FARON PHARMACEUTICALS OY stock shows the sell signal. See more of FARON PHARMACEUTICALS OY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.